Sanofi (SNY) EBITDA margin US GAAP (year values) |
|||||||||
| 2022 | 2023 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | 33.3% | 30.1% | 27.4% | 24.9% | 26.7% | 26.7% | ||
| Changes by years, y/y, % | +2pp | -3pp | -3pp | -2pp | +2pp | -11.0% | |||
Sanofi. EBITDA margin, %
Sanofi. EBITDA margin, changes, pp
Sanofi (SNY) EBITDA margin US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q3 | 2025Q2 | 2025Q4 | 2026Q1 | LTM ? | |||
| EBITDA margin, % | ? | 26.1% | 31.9% | 17.6% | 31.3% | 24.2% | 26.7% | |
| Changes by years, y/y, % | +7pp | 0pp | +24pp | -2pp | ||||
| Changes by quarters, q/q, % | +19pp | +6pp | -14pp | +14pp | -7pp | |||